A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics

Andrew Pipingas¹, Karen J Murphy², Courtney R Davis², Catherine Itsiopoulos³, Michael Kingsley^{4

5}, Andrew Scholey^{1

6}, Helen Macpherson⁷, Leonie Segal⁸, Jeff Breckon⁹, Anne-Marie Minihane¹⁰, Denny Meyer¹, Edward Ogden¹, Kathryn A Dyer², Emily Eversteyn¹, Roy J Hardman¹, Kaylass Poorun¹, Keri Justice¹, Maher Hana¹, Jonathan D Buckley², David White¹, Kade Davison², Jessie S Clark², Ella L Bracci², Greg Kennedy¹; MedWalk collaborative team

Affiliations

¹ Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, VIC, Australia.
² Alliance for Research in Exercise, Nutrition and Activity (ARENA), UniSA Allied Health and Human Performance & UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
³ School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.
⁴ Department of Exercise Sciences, The University of Auckland, Newmarket, New Zealand.
⁵ Holsworth Research Initiative, La Trobe University, Bendigo, VIC, Australia.
⁶ Nutrition Dietetics and Food, School of Clinical Sciences, Monash University, Notting Hill, VIC, Australia.
⁷ School of Exercise and Nutrition Sciences, Institute for Physical Activity and Nutrition, Deakin University, Burwood, VIC, Australia.
⁸ Economics and Social Policy Group, Allied Health and Human Performance, University of South Australia, Adelaide, SA, Australia.
⁹ School of Health and Life Sciences, Teesside University, Middlesbrough, UK.
¹⁰ Norwich Medical School, University of East Anglia, Norwich, UK.

PMID: 37781806
PMCID: PMC10657681
DOI: 10.3233/JAD-230641

A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics

Andrew Pipingas et al. J Alzheimers Dis. 2023.

. 2023;96(1):409-427.

doi: 10.3233/JAD-230641.

Authors

Affiliations

¹ Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, VIC, Australia.
² Alliance for Research in Exercise, Nutrition and Activity (ARENA), UniSA Allied Health and Human Performance & UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
³ School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.
⁴ Department of Exercise Sciences, The University of Auckland, Newmarket, New Zealand.
⁵ Holsworth Research Initiative, La Trobe University, Bendigo, VIC, Australia.
⁶ Nutrition Dietetics and Food, School of Clinical Sciences, Monash University, Notting Hill, VIC, Australia.
⁷ School of Exercise and Nutrition Sciences, Institute for Physical Activity and Nutrition, Deakin University, Burwood, VIC, Australia.
⁸ Economics and Social Policy Group, Allied Health and Human Performance, University of South Australia, Adelaide, SA, Australia.
⁹ School of Health and Life Sciences, Teesside University, Middlesbrough, UK.
¹⁰ Norwich Medical School, University of East Anglia, Norwich, UK.

PMID: 37781806
PMCID: PMC10657681
DOI: 10.3233/JAD-230641

Abstract

Background: Several clinical trials have examined diet and physical activity lifestyle changes as mitigation strategies for risk factors linked to cognitive decline and dementias such as Alzheimer's disease. However, the ability to modify these behaviors longer term, to impact cognitive health has remained elusive.

Objective: The MedWalk trial's primary aim is to investigate whether longer-term adherence to a Mediterranean-style diet and regular walking, delivered through motivational interviewing and cognitive-behavioral therapy (MI-CBT), can reduce age-associated cognitive decline and other dementia risk factors in older, independently living individuals without cognitive impairment.

Methods: MedWalk, a one-year cluster-randomized controlled trial across two Australian states, recruited 60-90-year-old people from independent living retirement villages and the wider community. Participants were assigned to either the MedWalk intervention or a control group (maintaining their usual diet and physical activity). The primary outcome is 12-month change in visual memory and learning assessed from errors on the Paired Associates Learning Task of the Cambridge Neuropsychological Test Automated Battery. Secondary outcomes include cognition, mood, cardiovascular function, biomarkers related to nutrient status and cognitive decline, MI-CBT effectiveness, Mediterranean diet adherence, physical activity, quality of life, cost-effectiveness, and health economic evaluation.Progress and Discussion:Although COVID-19 impacts over two years necessitated a reduced timeline and sample size, MedWalk retains sufficient power to address its aims and hypotheses. Baseline testing has been completed with 157 participants, who will be followed over 12 months. If successful, MedWalk will inform interventions that could substantially reduce dementia incidence and ameliorate cognitive decline in the community.

Trial registration: Registered on the Australia New Zealand Clinical Trials Registry ANZCTR 12620000978965 (https://www.anzctr.org.au).

Keywords: Alzheimer’s disease; Mediterranean diet; cardiovascular; cluster-randomized clinical trial; cognition; cognitive behavioral therapy; dementia; exercise; mood; motivational interviewing; physical activity.

PubMed Disclaimer

Conflict of interest statement

Helen Macpherson is an Editorial Board Member of this journal but was not involved in the peer-review process nor had access to any information regarding its peer-review.

Figures

See this image and copyright information in PMC

References

1. Pipingas A, Harris E, Tournier E, King R, Kras M, Stough CK (2010) Assessing the efficacy of nutraceutical interventions on cognitive functioning in the elderly. Curr Top Nutraceutical Res 8, 79–88.
1. Pase MP, Pipingas A, Kras M, Nolidin K, Gibbs AL, Wesnes KA, Scholey AB, Stough C (2010) Healthy middle-aged individuals are vulnerable to cognitive deficits as a result of increased arterial stiffness. J Hypertens 28, 1724–1729. - PubMed
1. Kennedy G, Hardman RJ, MacPherson H, Scholey AB, Pipingas A (2017) How does exercise reduce the rate of age-associated cognitive decline? A review of potential mechanisms. J Alzheimers Dis 55, 1–18. - PubMed
1. Scholey A (2018) Nutrients for neurocognition in health and disease: Measures, methodologies and mechanisms. Proc Nutr Soc 77, 73–83. - PubMed
1. World Health Organization (2019) Risk reduction of cognitive decline and dementia: WHO guidelines, Geneva. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Associated data

ANZCTR/ACTRN12620000978965

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics

Affiliations

A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Associated data

LinkOut - more resources

Full Text Sources

Medical